Watch Our Latest Webinar with Aureka on YouTube!

Preview text: Watch Our Latest Webinar with Aureka on YouTube! 96 Missed our Webinar with Aureka? Hello…

Wednesday, Sep 30, 2026 at 2:45 AM EasternHubSpot

SharewiseWatch Our Latest Webinar with Aureka on YouTube!

Fit to screenFull size

Using this email in an article? Credit: Sharewise email via They Sent It, with a link to this page. Full-size image

Subject: Watch Our Latest Webinar with Aureka on YouTube!
Preview text: Watch Our Latest Webinar with Aureka on YouTube! 96 Missed our Webinar with Aureka? Hello…
From: media@sharewise.com.au
Brand: Sharewise
ESP: HubSpot
Sent: Wed Sep 30, 2026, 2:45 AM ET
Size: 70 KB
Images: 11
Links: 16, 3 of them buttons
Subject length: 48 characters

Against Sharewise's usual

Sent in the 2 AM hour, which holds 8% of its emails; 16% arrive in the 9 PM hour. The subject is 48 characters; its average is 56.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: Sharewise <[email protected]>
Reply-To: [email protected]
Subject: Watch Our Latest Webinar with Aureka on YouTube!
Date: Wed, 30 Sep 2026 16:45:03 +1000
Message-ID domain: bf05.na3.hubspotemail.net
Return-Path domain: bf05.na3.hubspotemail.net
DKIM signature: d=bf05.na3.hubspotemail.net s=hs1; d=sharewise.com.au s=hs2-24076189
List-Unsubscribe: Present, one-click
Feedback-ID sender: HubSpot

Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To

	Oct 1, 2026 9:52 PM	Firmus Grid IPO: register your interest
	Oct 1, 2026 7:33 PM	Missed the Neurizon Webinar? Watch Now on YouTube!
	Sep 30, 2026 11:16 PM	Register for Trajan Group's Webinar – Ask Your Questions Live!
	Sep 30, 2026 2:45 AM	Watch Our Latest Webinar with Aureka on YouTube! (this email)
	Sep 28, 2026 9:34 PM	Join Our AEM Webinar with Executive Chair Richard & CEO/Managing Director Mick!
	Sep 22, 2026 11:12 PM	🎥 Missed the Dimerix Webinar, Subscriber? Watch Now!
	Sep 21, 2026 8:22 PM	Join Our Webinar with Neurizon Therapeutics!